Apr 15, 2025 15:00
BGLC - BioNexus Gene Lab Corp Common stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
5.19 -0.06 (-1.16%) | --- | --- | --- | 0.0 (0.0%) | 0.09 (1.76%) | 0.0 (0.0%) | 0.0 (0.0%) |
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- -0.343
- Basic P/E:
- Diluted P/E:
- -14.9563
- RSI(14) 1m:
- 0.0
- VWAP:
- 5.13
- RVol:
- 0.559
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Apr 19, 2024 21:36
Apr 18, 2024 18:52
Feb 14, 2024 18:18
Feb 14, 2024 13:12
Feb 13, 2024 18:13
Feb 13, 2024 14:43
Nov 27, 2023 18:41
Nov 27, 2023 14:46
Nov 27, 2023 13:10